Mark Cochran's bio:

Mark A. Cochran, PhD, is the Managing Director of Johns Hopkins Healthcare Solutions. Dr. Cochran’s professional experience spans all levels of the drug discovery, development and healthcare value chain including operational and executive roles in academic, venture capital, pharmaceutical and biotechnology industries. His previous experience includes Bayer Pharmaceuticals, last serving as Vice President of Business Development, Biotechnology, in Berkeley, California. Other positions held during his tenure at Bayer included Project Director of Recombinant Factor VIII (Kogenate), and Head of Molecular Biology and Biochemistry in Wuppertal Germany. From 2006 to 2008 Dr. Cochran was the CEO and executive director of the Blanchette Rockefeller Neurosciences Institute (BRNI, www.brni.org) which targets advanced research of memory and memory disorders, particularly Alzheimer’s disease. Dr. Cochran’s experience in venture capital includes MDS Capital Corp. and NeuroVentures (Charlottesville, VA; www.neuroventures.com), as senior managing director. NeuroVentures was a fund specializing in the neurosciences and invested in companies developing drugs, devices and other medical technologies for clinical neuroscience. At MDS Capital Corp., a Toronto-based Healthcare venture capital group, he was responsible for their San Francisco venture business and several MDS invested companies. Dr. Cochran holds a doctorate in microbiology and immunology from Queen’s University, Kingston, Ontario; a master’s in microbiology from the University of Guelph, Ontario, and a bachelor’s degree from the University of Toronto. After he completed a postdoctoral fellowship at the National Institutes of Health, Dr. Cochran co-founded MicroGeneSys, Inc., a Connecticut-based vaccine company (now called Protein Sciences) where he was a co-inventor and co-developer of candidate vaccines for HIV, HBV, malaria, influenza and others. He is listed as the author on 22 scientific papers, 70 abstracts and six patents. Disclosure: Mark Cochran, PhD has disclosed that he has no relevant financial relationships to report.

Mark Cochran's posts:

Technology Commercialization Through Partnerships

Johns Hopkins HealthCare Solutions (“Solutions”) is a recently created division of JHHC. Solutions is structured to commercialize innovative knowledge-based products and [MORE]